{"id":7500,"date":"2025-05-23T06:30:00","date_gmt":"2025-05-23T06:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/"},"modified":"2025-05-23T06:30:00","modified_gmt":"2025-05-23T06:30:00","slug":"realheart-publicerar-arsredovisning-for-2024","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/","title":{"rendered":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>V\u00e4ster\u00e5s, 23 maj 2025. Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2024.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>\u00c5rsredovisningen inklusive revisionsber\u00e4ttelse (Eng) \u00e5terfinns p\u00e5\u00a0<strong><a href=\"http:\/\/www.realheart.se\/\" rel=\"noopener\" target=\"_blank\">www.realheart.se<\/a><\/strong>\u00a0samt som bilaga i detta pressmeddelande.\u00a0<\/p>\n<p>Den engelska versionen \u00e4r en \u00f6vers\u00e4ttning fr\u00e5n den svenska.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-ddde9c982a0b\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information, kontakta:<\/strong><br \/>Ina Laura Perkins, VD<br \/>Tel: +46 (0) 70 406 49 21<br \/>E-post: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"noopener\" target=\"_blank\">inalaura.perkins@realheart.se<\/a><br \/>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, <a href=\"http:\/\/www.skmg.se\" rel=\"noopener\" target=\"_blank\">www.skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-0285b54ad9f5\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><br \/>Scandinavian Real Heart AB (publ) utvecklar det f\u00f6rsta konstgjorda hj\u00e4rtat som efterliknar det m\u00e4nskliga hj\u00e4rtats form, funktion och blodfl\u00f6desm\u00f6nster. Dessa unika produktegenskaper ger helt nya m\u00f6jligheter att r\u00e4dda liv och ge patienter en god livskvalitet i v\u00e4ntan p\u00e5 en hj\u00e4rttransplantation. I framtiden kan konstgjorda hj\u00e4rtan ocks\u00e5 bli ett alternativ till transplantation f\u00f6r bredare grupper av patienter med sv\u00e5r hj\u00e4rtsvikt. Realheart\u00ae TAH (Total Artificial Heart) utv\u00e4rderas nu i omfattande prekliniska studier inf\u00f6r en f\u00f6rsta klinisk studie p\u00e5 patienter. Bolagets aktier \u00e4r upptagna till handel p\u00e5 Nasdaq Stockholm First North Growth Market. F\u00f6r mer information, bes\u00f6k <a href=\"https:\/\/realheart.se\/sv\/\" rel=\"noopener\" target=\"_blank\">https:\/\/realheart.se\/sv\/<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/81a0384e-81c4-4cf6-97ee-efdfef1dba23\/realheart-annual-report-2024-eng-incl-auditors-report-final.pdf\" rel=\"noopener\" target=\"_blank\">Realheart Annual Report 2024 ENG Incl Auditor&#039;s Report Final<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/81a0384e-81c4-4cf6-97ee-efdfef1dba23\/realheart-annual-report-2024-eng-incl-auditors-report-final.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/81a0384e-81c4-4cf6-97ee-efdfef1dba23\/realheart-annual-report-2024-eng-incl-auditors-report-final.pdf?type=jpg\"><\/span>Realheart Annual Report 2024 ENG Incl Auditor's Report Final<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>V\u00e4ster\u00e5s, 23 maj 2025. Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2024. \u00c5rsredovisningen inklusive revisionsber\u00e4ttelse (Eng) \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Den engelska versionen \u00e4r en \u00f6vers\u00e4ttning fr\u00e5n den svenska. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart AB (publ)&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-7500","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart\" \/>\n<meta property=\"og:description\" content=\"V\u00e4ster\u00e5s, 23 maj 2025. Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2024. \u00c5rsredovisningen inklusive revisionsber\u00e4ttelse (Eng) \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Den engelska versionen \u00e4r en \u00f6vers\u00e4ttning fr\u00e5n den svenska. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart AB (publ)...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2024\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2024\\\/\",\"name\":\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2025-05-23T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2024\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart","og_description":"V\u00e4ster\u00e5s, 23 maj 2025. Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2024. \u00c5rsredovisningen inklusive revisionsber\u00e4ttelse (Eng) \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Den engelska versionen \u00e4r en \u00f6vers\u00e4ttning fr\u00e5n den svenska. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart AB (publ)...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/","name":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2025-05-23T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2024"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/7500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=7500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}